Responsibility First
Corporate Governance
Message From Brian K. Hutchison, CEO
At RTI Biologics, Inc., and all affiliated companies (the “Company” or “RTI”), our business is founded on responsibility, integrity and ethical behavior. Every day we are entrusted with the priceless gift of donated human tissue to create safe, biological implants to help people across the world live healthier lives. We are committed to preserving that trust and operating in an honest, responsible manner when dealing with all Company stakeholders, including recovery agencies, donor families, employees, distributors, surgeons, patients, vendors and shareholders.
This Code of Conduct ensures that we are not only in compliance with all applicable laws, rules and regulations, but also that we operate in an honest and ethical manner and gives instructions on how to report potential violations of the Code. Each employee of the Company is held fully accountable for adhering to this Code.
In the corporate world, integrity and honesty is always important. When a Company is tasked with such a crucial task as caring for the gift of donated human tissue to help others, as the Company is, these hallmarks are vital. We will continue to operate on this foundation. Thank you for your commitment to the Company and to this vitally important framework for the Company.
Brian K. Hutchison
Corporate Documents
Principles & Ethics
- Download RTI Code of Conduct
- Download RTI Code Of Ethics For Senior Financial Professionals
- Download RTI California Compliance Program Declaration
RTI Board of Directors
Brian K. Hutchison
Julianne M. Bowler
Phillip R. Chapman
Roy D. Crowninshield
Peter F. Gearen, M.D.
Gregory P. Rainey
Adrian J.R. Smith
Dean H. Bergy
Board Committees & Charters
Audit Committee
Dean H. Bergy
Phillip R. Chapman
Peter F. Gearen, M.D.
Audit Committee Charter
Compensation Committee
Roy D. Crowninshield
Adrian J.R. Smith
Gregory P. Rainey
Compensation Committee Charter
Nominating & Governance Committee
Julianne M. Bowler
Adrian J.R. Smith
Nominating Committee Charter
Science & Technology Committee
Roy D. Crowninshield
Peter F. Gearen, M.D.
Gregory P. Rainey
Science & Technology Committee Charter
Stock Ticker
Current Stock Info
» Price: 4.11
» Change: +0.05
» Last Update: 4:00pm
Stay Informed, subscribe to our news list.
